EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Comparing Adult Smokers Who Switched to JUUL versus Continuing Smokers: Biomarkers of Exposure and of Potential Harm and Respiratory Symptoms

Saul Shiffman iD, Douglas R Oliveri, Nicholas I Goldenson, Qiwei Liang, Ryan A Black, Snigdha Mishra

Nicotine and Tobacco Research · 2024

DOI: 10.1093/ntr/ntad197 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Nicotine and Tobacco Research, 2024. Verfasst von Saul Shiffman und 5 weiteren Autor:innen. Beteiligte Einrichtung: PinneyAssociates, Inc., Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Tobacco Products, Electronic Nicotine Delivery Systems. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: JUUL Labs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Real-world evidence on exposure to harmful and potentially harmful constituents (HPHCs) and on biological effects in cigarette smokers who switch to electronic nicotine delivery systems (ENDS) can inform the health effects of switching. Aims and Methods This cross-sectional, observational study assessed adults who had smoked ≥10 cigarettes/day for ≥10 years, comparing 124 continuing cigarette smokers (Smokers) to 140 former smokers who switched to JUUL-brand ENDS exclusively for ≥6 months (Switchers). Assessments included biomarkers of exposure (BOEs) to select HPHCs, biomarkers of potential harm (BOPHs) related to smoking-related diseases, psychometric assessments of dependence on cigarettes and ENDS, respectively, and respiratory symptoms. Planned analyses compared geometric means, adjusted for demographic covariates; further analyses adjusted for additional lifestyle and smoking history covariates.

Results

Nicotine levels were significantly higher in Switchers (median time switched = 3 years), who were unusually heavy users of JUUL. All other BOEs, including NNAL and HPMA3 (primary endpoints), were significantly lower in Switchers than Smokers. Most BOPHs (sICAM-1 [primary], and eg, white blood cell count, MCP1, HbA1c) were significantly lower in Switchers than Smokers; HDL was significantly higher. Switchers reported significantly lower dependence on JUUL than Smokers did on cigarettes, and respiratory symptom scores were significantly lower among Switchers than Smokers.

Conclusions

Compared to continuing smokers, smokers who switched to JUUL had substantially lower exposures to multiple HPHCs, favorable differences in markers of inflammation, endothelial function, oxidative stress, and cardiovascular risk, and fewer respiratory symptoms. These findings suggest that switching from cigarettes to JUUL likely reduces smokers’ health risks.

Implications

Short-term confinement studies and randomized clinical trials demonstrate that adult smokers who switch completely to ENDS experience substantial reductions in exposure to many smoking-related toxicants. This study extends those findings to longer periods of switching to JUUL-brand ENDS (almost 3 years on average) under naturalistic use conditions in real-world settings and also found that switching to JUUL resulted in favorable differences in BOPHs more proximally related to smoking-induced disease, as well as in respiratory symptoms. Smokers who switch to ENDS reduce their exposure to toxicants, likely reducing their disease risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tobacco ProductsElectronic Nicotine Delivery SystemsAdultHumansSmokersCross-Sectional StudiesSmokingNicotineBiomarkersHazardous Substances

Substanzen

NicotineBiomarkersHazardous Substances

Autor:innen und Institutionen

  • PinneyAssociates, Inc., Pittsburgh, PA, USA.
  • Behavioral and Clinical Sciences, Juul Labs, Inc., Washington, DC, USA.
  • Population and Clinical Sciences, Juul Labs, Inc., Washington, DC, USA.
  • Regulatory Sciences, Juul Labs, Inc., Washington, DC, USA.

ORCID-Profile: Saul Shiffman

Förderung

  • JUUL Labs

Zitieren

APA

Shiffman, S., Oliveri, D. R., Goldenson, N. I., Liang, Q., Black, R. A., & Mishra, S. (2024). Comparing Adult Smokers Who Switched to JUUL versus Continuing Smokers: Biomarkers of Exposure and of Potential Harm and Respiratory Symptoms. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntad197

Vancouver

Shiffman S, Oliveri DR, Goldenson NI, Liang Q, Black RA, Mishra S. Comparing Adult Smokers Who Switched to JUUL versus Continuing Smokers: Biomarkers of Exposure and of Potential Harm and Respiratory Symptoms. Nicotine and Tobacco Research. 2024. doi:10.1093/ntr/ntad197

BibTeX
@article{Shiffman2024,
  author = {Shiffman, Saul and Oliveri, Douglas R and Goldenson, Nicholas I and Liang, Qiwei and Black, Ryan A and Mishra, Snigdha},
  title = {Comparing Adult Smokers Who Switched to JUUL versus Continuing Smokers: Biomarkers of Exposure and of Potential Harm and Respiratory Symptoms},
  journal = {Nicotine and Tobacco Research},
  year = {2024},
  doi = {10.1093/ntr/ntad197}
}
Kostenlos starten →